24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Kadimastem
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:34
Intel's stock rout obscures a growing opportunity in the AI server market
14:23
LinkedIn’s AI recruiters are changing the rules of the job hunt
14:12
Israel’s KFC branches get a temporary lifeline as operator faces insolvency
14:06
Moody’s raises Israel growth forecast but warns over institutions and foreign relations
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Cyber startup Cyera eyes $20 billion valuation in new funding talks
3
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
4
Intel’s $600 million question: How the Kiryat Gat explosion hit its forecast
5
BrainPOP's mind-blowing deal: Israeli founder nets $875 million from deal with Lego
More news
Kadimastem
2 stories about Kadimastem
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019